Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.05
-1.05 (-5.80%)
At close: Sep 17, 2025, 4:00 PM EDT
17.26
+0.21 (1.23%)
Pre-market: Sep 18, 2025, 5:15 AM EDT

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,66611,6149,02111,3757,84113,454
Upgrade
Market Cap Growth
-88.75%28.75%-20.70%45.06%-41.72%39.87%
Upgrade
Enterprise Value
2,23011,8318,67710,9077,42012,422
Upgrade
Last Close Price
17.05121.5996.43129.5890.05170.49
Upgrade
PE Ratio
-49.37----
Upgrade
Forward PE
-15.47----
Upgrade
PS Ratio
0.666.117.2612.1911.1724.91
Upgrade
PB Ratio
1.237.6010.5029.558.4517.66
Upgrade
P/TBV Ratio
1.267.7410.8730.148.5817.98
Upgrade
P/FCF Ratio
-----532.53
Upgrade
P/OCF Ratio
-----125.19
Upgrade
EV/Sales Ratio
0.906.226.9811.6910.5723.00
Upgrade
EV/EBITDA Ratio
55.5546.25----
Upgrade
EV/EBIT Ratio
-54.25----
Upgrade
EV/FCF Ratio
-----491.69
Upgrade
Debt / Equity Ratio
1.000.881.614.201.231.41
Upgrade
Debt / EBITDA Ratio
8.453.74----
Upgrade
Debt / FCF Ratio
-----42.47
Upgrade
Asset Turnover
0.700.530.390.300.230.23
Upgrade
Inventory Turnover
2.592.103.905.214.123.90
Upgrade
Quick Ratio
1.532.743.233.635.054.99
Upgrade
Current Ratio
2.894.203.954.135.755.97
Upgrade
Return on Equity (ROE)
-4.76%19.71%-86.15%-107.16%-49.57%-70.14%
Upgrade
Return on Assets (ROA)
-0.02%3.77%-5.24%-10.68%-9.04%-14.67%
Upgrade
Return on Capital (ROIC)
-0.02%5.34%-7.90%-16.47%-14.21%-20.84%
Upgrade
Return on Capital Employed (ROCE)
-6.70%----
Upgrade
Earnings Yield
-3.48%2.02%-5.94%-6.19%-5.34%-4.12%
Upgrade
FCF Yield
-27.10%-2.95%-6.40%-3.13%-6.14%0.19%
Upgrade
Buyback Yield / Dilution
0.99%-16.75%-5.53%-7.75%-4.24%-5.90%
Upgrade
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q